Veer Bhavnagri, General Counsel at Allogene Therapeutics, Inc. (ALLO), sold 49,200 shares at $37.03 ($1.8M) on 2020-10-01, disclosed to the SEC on 2020-10-02.
Open-market sale of $1.8M ALLO by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.21 | 16,215 | $587K | 32.7% |
| 2 | $36.21 | 16,215 | $587K | 32.7% |
| 3 | $37.03 | 7,985 | $296K | 16.5% |
| 4 | $37.03 | 7,985 | $296K | 16.5% |
| 5 | $37.73 | 800 | $30K | 1.7% |
| Total | $36.50 avg | 49,200 |
| $1.8M |
| 100% |
| Filing → |
| ALLO | SELL | 2022-12-19 | $42K | — | Filing → |
| ALLO | SELL | 2022-03-17 | $136K | — | Filing → |
| ALLO | SELL | 2021-09-17 | $124K | — | Filing → |